Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Renal Sympathetic Denervation in Moderate to Severe Chronic Kidney Disease [NA]
Clinical trial update indicates that a study of renal sympathetic denervation in patients with hypertension and chronic kidney disease has c…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives [Phase 1]
A Phase 1 trial by GlaxoSmithKline evaluating the potential for orthostatic hypotension in elderly hypertensive individuals has completed.
-
FDA approval · 2017-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved Zydus Pharmaceuticals USA's original application for diltiazem hydrochloride as a generic product, enabling its use for the man…
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy. [Phase 4]
Phase 4 trial assessing blood pressure control with nifedipine GITS 60 mg in Chinese hypertensive patients uncontrolled on starting-dose mon…
-
FDA approval · 2017-08-03FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for Benazepril hydrochloride and hydrochlorothiazide, submitted by Padagis US LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-08-03Clinical Trial Update: Active and Healthy Brotherhood: A Program for Chronic Disease Self-Management for Black Men [NA]
A ClinicalTrials.gov update describes an active program focused on chronic disease self-management for Black men. No phase or status details…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan. [Phase 3]
A Phase 3 trial in Chinese patients with mild-to-moderate hypertension compared the efficacy of Co-Diovan (valsartan/amlodipine) with Diovan…
-
FDA approval · 2017-07-28FDA Approved: NADOLOL — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved Nadolol as a generic drug in an Original Application (ANDA) for Zydus Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers [Phase 1]
Phase 1 crossover study in healthy volunteers comparing the bioavailability of two fixed-dose combination tablets of amlodipine and losartan…
-
CLINICAL_TRIALS research · 2017-07-25Clinical Trial Update: the Effect of Tracleer on Tourniquet-associated Hypertension [Phase 4]
Phase 4 clinical trial update examining the effect of Tracleer (bosentan) on tourniquet-associated hypertension; current status is unknown.
-
FDA approval · 2017-07-25FDA Approved: TELMISARTAN — Original Application (Modavar Pharmaceuticals LLC)
The FDA approved Modavar Pharmaceuticals LLC's original application for telmisartan, enabling a generic version of the antihypertensive drug…
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea [NA]
This clinical trial update reports the completion of a study evaluating continuous positive airway pressure (CPAP) to improve milder obstruc…
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Levels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary Study
A completed SPS3 ancillary study that examined inflammatory marker levels in people with stroke as part of secondary prevention research.
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Dietary Intake of Whole Walnuts in Adult Subjects Under Low Cardiovascular Risk [NA]
This clinical trial registry entry indicates the completion of a study examining how dietary intake of whole walnuts affects cardiovascular …
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Clinical Trial of Dietary Protein and Blood Pressure [NA]
A Tulane University–sponsored clinical trial evaluated the effect of dietary protein on blood pressure and is completed with results posted …
-
FDA approval · 2017-07-21FDA Approved: ZESTRIL — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for ZESTRIL (lisinopril) submitted by Upsher-Smith Laboratories.
-
FDA label_change · 2017-07-21FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
The FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) by Almatica Pharma Inc., resulting in update…
-
FDA approval · 2017-07-21FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) submitted by Novartis Pharmaceutic…
-
FDA approval · 2017-07-21FDA Approved: VASERETIC — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for VASERETIC (enalapril maleate and hydrochlorothiazide) filed by Bausch Health US, LLC.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Pharmacokinetic Drug-drug Interaction of CKD-330 and D086 [Phase 1]
This phase 1 pharmacokinetic study assesses potential drug-drug interaction between CKD-330 and D086.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: An Analysis of Diabetes Control in Puerto Rico
This document summarizes results from a completed clinical trial evaluating diabetes control in Puerto Rico, with participants who also had …
-
CLINICAL_TRIALS research · 2017-07-21Clinical Trial Update: Support for Cardiovascular Health in African American Primary Care Patients [NA]
This clinical trial (NCT00948714) conducted by the University of Pennsylvania focusing on cardiovascular health in African American primary …
-
FDA approval · 2017-07-21FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a generic fixed-dose combination tablet of losartan potassium and hydrochlorothiazide from Unichem Pharmaceuticals (USA), I…
-
FDA approval · 2017-07-19FDA Approved: CANDESARTAN — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for candesartan from Macleods Pharmaceuticals Limited, enabling a generic version of the drug.
-
FDA approval · 2017-07-17FDA Approved: AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for a fixed-dose combination generic of amlodipine besylate and olmesartan medoxo…